193 related articles for article (PubMed ID: 28577966)
1. Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection.
García-Broncano P; Ceña-Diez R; de la Mata FJ; Gómez R; Resino S; Muñoz-Fernández MÁ
Eur J Pharmacol; 2017 Sep; 811():155-163. PubMed ID: 28577966
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide.
Sepúlveda-Crespo D; Lorente R; Leal M; Gómez R; De la Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
Nanomedicine; 2014 Apr; 10(3):609-18. PubMed ID: 24135563
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.
Vacas-Córdoba E; Galán M; de la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
Int J Nanomedicine; 2014; 9():3591-600. PubMed ID: 25114528
[TBL] [Abstract][Full Text] [Related]
4. Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment/therapy.
Sepúlveda-Crespo D; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
Nanomedicine; 2015 Aug; 11(6):1481-98. PubMed ID: 25835558
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen.
Ceña-Diez R; García-Broncano P; de la Mata FJ; Gómez R; Muñoz-Fernández MÁ
Int J Nanomedicine; 2016; 11():2443-50. PubMed ID: 27313457
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro.
Córdoba EV; Arnáiz E; De La Mata FJ; Gómez R; Leal M; Pion M; Muñoz-Fernández MA
AIDS; 2013 Aug; 27(13):2053-8. PubMed ID: 23612005
[TBL] [Abstract][Full Text] [Related]
7. G2-S16 sulfonate dendrimer as new therapy for treatment failure in HIV-1 entry inhibitors.
Rodríguez-Izquierdo I; Natalia C; García F; Los Ángeles Muñoz-Fernandez M
Nanomedicine (Lond); 2019 May; 14(9):1095-1107. PubMed ID: 31066644
[No Abstract] [Full Text] [Related]
8. Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.
Briz V; Sepúlveda-Crespo D; Diniz AR; Borrego P; Rodes B; de la Mata FJ; Gómez R; Taveira N; Muñoz-Fernández MÁ
Nanoscale; 2015 Sep; 7(35):14669-83. PubMed ID: 26274532
[TBL] [Abstract][Full Text] [Related]
9. Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.
Relaño-Rodríguez I; Juárez-Sánchez R; Pavicic C; Muñoz E; Muñoz-Fernández MÁ
J Nanobiotechnology; 2019 May; 17(1):69. PubMed ID: 31113488
[TBL] [Abstract][Full Text] [Related]
10. Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission.
Vacas Córdoba E; Arnaiz E; Relloso M; Sánchez-Torres C; García F; Pérez-Álvarez L; Gómez R; de la Mata FJ; Pion M; Muñoz-Fernández MÁ
AIDS; 2013 May; 27(8):1219-29. PubMed ID: 23925376
[TBL] [Abstract][Full Text] [Related]
11. Anti-Human Immunodeficiency Virus Activity of Thiol-Ene Carbosilane Dendrimers and Their Potential Development as a Topical Microbicide.
Sánchez-Rodríguez J; Díaz L; Galán M; Maly M; Gómez R; Javier de la Mata F; Jiménez JL; Muñoz-Fernández MA
J Biomed Nanotechnol; 2015 Oct; 11(10):1783-98. PubMed ID: 26502641
[TBL] [Abstract][Full Text] [Related]
12. Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion.
Guerrero-Beltran C; Rodriguez-Izquierdo I; Serramia MJ; Araya-Durán I; Márquez-Miranda V; Gomez R; de la Mata FJ; Leal M; González-Nilo F; Muñoz-Fernández MA
Bioconjug Chem; 2018 May; 29(5):1584-1594. PubMed ID: 29570280
[TBL] [Abstract][Full Text] [Related]
13. Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission.
Sepúlveda-Crespo D; Sánchez-Rodríguez J; Serramía MJ; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
Nanomedicine (Lond); 2015; 10(6):899-914. PubMed ID: 25867856
[TBL] [Abstract][Full Text] [Related]
14. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
[TBL] [Abstract][Full Text] [Related]
15. Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1.
Vacas-Córdoba E; Maly M; De la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
Int J Nanomedicine; 2016; 11():1281-94. PubMed ID: 27103798
[TBL] [Abstract][Full Text] [Related]
16. Sulfonate-ended carbosilane dendrimers with a flexible scaffold cause inactivation of HIV-1 virions and gp120 shedding.
Sepúlveda-Crespo D; de la Mata FJ; Gómez R; Muñoz-Fernández MA
Nanoscale; 2018 May; 10(19):8998-9011. PubMed ID: 29726564
[TBL] [Abstract][Full Text] [Related]
17. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
Roan NR; Sowinski S; Münch J; Kirchhoff F; Greene WC
J Biol Chem; 2010 Jan; 285(3):1861-9. PubMed ID: 19897482
[TBL] [Abstract][Full Text] [Related]
18. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
[TBL] [Abstract][Full Text] [Related]
19. Emergence of Nanotechnology to Fight HIV Sexual Transmission: The Trip of G2-S16 Polyanionic Carbosilane Dendrimer to Possible Pre-Clinical Trials.
Relaño-Rodríguez I; Muñoz-Fernández MÁ
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321835
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents.
Relaño-Rodríguez I; Espinar-Buitrago MS; Martín-Cañadilla V; Gómez-Ramirez R; Jiménez JL; Muñoz-Fernández MA
J Nanobiotechnology; 2021 Mar; 19(1):65. PubMed ID: 33658029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
